Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
Clinical Trials Arena on MSN
Rivus Pharmaceuticals begins patient dosing in Phase II AMPLIFY trial
The trial will enrol around 180 adults with F2/F3 MASH.
Objective To investigate whether aligning exercise timing with chronotype enhances cardiometabolic and sleep-related benefits ...
Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
MedPage Today on MSN
Six 'Superretractors' Responsible for Large Number of Retracted Clinical Trials
Editorialists call for better screening of authors ...
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...
LifeNet Health, a global leader in regenerative medicine, has received the Best Randomized Controlled Trial Award at the 2026 CAMPs Awards for its Matrion® diabetic foot ulcer study. In this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results